Disease: Myasthenia gravis
- A new gene signature associated with disulfidptosis that forecasts myasthenia gravis and suggests infiltration of immune microenvironment in thymoma patients
- A proof-of-concept study: advantages of the subxiphoid over the lateral intercostal approach
- A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis
- A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in England
- Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia
- An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study
- Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients
- Autoimmune and Non-Autoimmune Comorbidities in Myasthenic Patients of East-European Descent: A Case-Control Study
- Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs
- Beyond T cell toxicity-Intrathecal chemokine C-X-C motif ligand indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review
- Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
- CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
- Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model
- Clinical characteristics of late-onset myasthenia gravis
- Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China
- Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective
- Comparison of outcomes in patients with and without neurologic diseases undergoing holmium laser enucleation of the prostate
- Construction of ceRNA network mediated by circRNAs screening from microarray and identification of novel biomarkers for myasthenia gravis
- Corrigendum to "Study of serum exosome miRNA as a biomarker for early onset adult ouclar myasthenia gravis" [Gene 896 (2024) 148034]
- COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: A lesson from Northern India
- COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China
- CRE24-047: A Rare Case of Immune Checkpoint Inhibitor Induced Seronegative Myasthenia Gravis
- Dental Adverse Effects of Anti-CD20 Therapies
- Detecting muscle-specific kinase myasthenia gravis in atypical presentations
- Detection of Autoantibodies Against the Acetylcholine Receptor, Evaluation of Commercially Available Methodologies: Fixed Cell-Based Assay, Radioimmunoprecipitation Assay and Enzyme-Linked Immunosorbent Assay1
- Development of Upper Extremity Deep Vein Thrombosis in a Patient With Seronegative Myasthenia Gravis: A Case Report and Review of Literature
- Disruption of Neuromuscular Junction Following Spinal Cord Injury and Motor Neuron Diseases
- Eculizumab in myasthenia gravis: A review
- Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis
- Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison
- Efgartigimod as a novel FcRn inhibitor for autoimmune disease
- Empirical Pyridostigmine in a Patient with Difficult Weaning from Mechanical Ventilation after Traumatic Brain Injury
- Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study
- Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data
- Epidemiology, Patient Characteristics, and Treatment Patterns of Myasthenia Gravis in Taiwan: A Population-Based Study
- Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis
- Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy
- Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study
- Immune Checkpoint Inhibitor-induced Myositis
- Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis-A Case Series
- Impact of therapeutic plasma exchange on intact protein S, apolipoproteins, and thrombin generation
- Improving Outcome in Severe Myasthenia Gravis and Guillain-Barre Syndrome
- Inappropriate placement of urinary catheters into the ureter: A case report and literature review
- Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis
- Juvenile Myasthenia Gravis in North Texas: Clinical Features, Treatment Response, and Outcomes
- Juvenile ocular myasthenia gravis: a report of two cases
- Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration
- Life-Long Aerobic Exercise is a Non-Pharmacological Approach for Inducing Autophagy and Delaying Muscle Atrophy in the Aging Population
- Long-term follow-up of non-myasthenic patients with early-stage thymoma who underwent extended thymectomy or limited resection
- Long-term Healthcare Resource Utilization and Costs among Patients with Myasthenia Gravis: A Swedish Nationwide Population-based Study
- Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
- Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis
- Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis
- Monoclonal antibodies in neuro-ophthalmology
- Morphometric Analysis of the Thymic Epithelial Cell (TEC) Network Using Integrated and Orthogonal Digital Pathology Approaches
- MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets
- Myasthenia Gravis - Update
- Myasthenia Gravis in Pregnancy and the Newborn
- Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
- Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
- Novel immunomodulatory therapies in myasthenia gravis
- Ocular Myasthenia Gravis As Unilateral Ptosis and External Ophthalmoplegia: A Case Report
- Omalizumab-induced ocular myasthenia gravis?
- Oral salbutamol for symptomatic treatment in MuSK antibody-positive myasthenia gravis: a single-centre experience
- Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations
- Peribulbar Corticosteroids for Ocular Myasthenia Gravis
- Perspectives of people with myasthenia gravis on physical activity and experience of physical activity advice from health professionals in the Australian context: a qualitative study
- Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis
- Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review
- Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis
- Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis
- Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
- Recommendations for the management of myasthenia gravis in Belgium
- Respiratory paralysis in a patient with myasthenia gravis after ingestion of marine carnivorous gastropods: A case report
- Rethinking the Likelihood of Myasthenia Gravis Exacerbations
- Retracted: Analysis on the Clinical Effect of High-Dose Glucocorticoids Combined with Immunosuppressants on Patients with Myasthenia Gravis Undergoing Video-Assisted Thoracoscopic Surgery
- Robotic thymectomy in thymic tumors: a multicenter, nation-wide study
- Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning
- Serum globulin in children with myasthenia gravis: predicting relapse and prognosis
- SFEMG in extensor digitorum communis and tibialis anterior: Relative sensitivity in myasthenia gravis
- Single breath count test and its applications in clinical practice: a systematic review
- Small molecule improves muscle function in myasthenia gravis
- Social support and medication adherence among adult myasthenia gravis patients in China: the mediating role of mental health and self-efficacy
- Structure and function of therapeutic antibodies approved by the US FDA in 2023
- Systemic Inflammatory Response Index, a Potential Inflammatory Biomarker in Disease Severity of Myasthenia Gravis: A Pilot Retrospective Study
- Taste disorders and alopecia in myasthenia gravis
- Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool
- Tetramine in Patients with Myasthenia Gravis
- The analysis of factors affecting medication adherence in patients with myasthenia gravis: a cross-sectional study
- The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study
- The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment
- The rate of QMGS change predicts recurrence after thymectomy in myasthenia gravis
- Therapeutic Plasma Exchange in AChR-Ab Positive Generalized Myasthenia Gravis: A Real World Study About Its Early Response
- Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan
- Thymoma Exhibiting Spontaneous Regression With Cystic Change Due to Acute Infarction: A Case Report and Literature Review
- Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis
- Trends from two decades of orphan designations in paediatric rare neuromuscular diseases
- Uraemic brainstem encephalopathy mimicking ocular myasthenia: a case report
- Use of sugammadex for neuromuscular blockade reversal on a dog with myasthenia gravis undergoing thymoma resection
- Zilucoplan (Zilbrysq) for myasthenia gravis